# LEVOLEUCOVORIN CALCIUM
> **ANDA206516** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LLC · Approved 2017-02-13
## Drug
- **FDA Application Number:** ANDA206516
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOLEUCOVORIN CALCIUM
- **Generic name:** Levoleucovorin Calcium
- **Active ingredients:** LEVOLEUCOVORIN CALCIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS LLC
- **First approval:** 2017-02-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206516)
---
*MORVS · CC0 1.0*